BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2033515)

  • 1. MK-801 and related compounds in monkeys: discriminative stimulus effects and effects on a conditional discrimination.
    France CP; Moerschbaecher JM; Woods JH
    J Pharmacol Exp Ther; 1991 May; 257(2):727-34. PubMed ID: 2033515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analgesic effects of phencyclidine-like drugs in rhesus monkeys.
    France CP; Snyder AM; Woods JH
    J Pharmacol Exp Ther; 1989 Jul; 250(1):197-201. PubMed ID: 2501476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the discriminative stimulus effects of N-methyl- D-aspartate ligands under different ethanol training conditions in the cynomolgus monkey ( Macaca fascicularis).
    Vivian JA; Waters CA; Szeliga KT; Jordan K; Grant KA
    Psychopharmacology (Berl); 2002 Jul; 162(3):273-81. PubMed ID: 12122485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
    Koek W; Woods JH; Winger GD
    J Pharmacol Exp Ther; 1988 Jun; 245(3):969-74. PubMed ID: 2838610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of kappa agonists and dexoxadrol on the acquisition of conditional discriminations in monkeys.
    Moerschbaecher JM; Brocklehurst C; Devia C; Faust WB
    J Pharmacol Exp Ther; 1987 Nov; 243(2):737-44. PubMed ID: 2824758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phencyclidine-like discriminative stimulus properties of the stereoisomers of dioxadrol.
    Slifer BL; Balster RL
    Subst Alcohol Actions Misuse; 1984-1985; 5(6):273-80. PubMed ID: 6545061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The self-administration of MK-801 can depend upon drug-reinforcement history, and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys.
    Beardsley PM; Hayes BA; Balster RL
    J Pharmacol Exp Ther; 1990 Mar; 252(3):953-9. PubMed ID: 2181113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of phencyclidine-type drugs in rats discriminating fentanyl from saline: pharmacological and behavioral characterization of intermediate levels of drug lever selection.
    Koek W; Colpaert FC; Vignon J
    J Pharmacol Exp Ther; 1993 Feb; 264(2):746-56. PubMed ID: 8437123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-D-aspartate channel blocker memantine.
    Nicholson KL; Jones HE; Balster RL
    Behav Pharmacol; 1998 May; 9(3):231-43. PubMed ID: 9832937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of prototype opioid agonists on the acquisition of conditional discriminations in monkeys.
    Moerschbaecher JM; Thompson DM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):738-48. PubMed ID: 6887010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of phencyclidine, etoxadrol and dexoxadrol in the pigeon.
    Leander JD
    Subst Alcohol Actions Misuse; 1982; 3(4):197-203. PubMed ID: 6132451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-methyl-D-aspartate receptors in associative eyeblink conditioning: both MK-801 and phencyclidine produce task- and dose-dependent impairments.
    Thompson LT; Disterhoft JF
    J Pharmacol Exp Ther; 1997 May; 281(2):928-40. PubMed ID: 9152403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus effects of ethanol: effect of training dose on the substitution of N-methyl-D-aspartate antagonists.
    Grant KA; Colombo G
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1241-7. PubMed ID: 8450461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 attenuates the rate-decreasing effects of NMDA in rhesus monkeys without producing ketamine-like discriminative stimulus effects.
    France CP; Woods JH; Ornstein P
    Eur J Pharmacol; 1989 Jan; 159(2):133-9. PubMed ID: 2651134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance of behavior by ketamine and related compounds in rhesus monkeys with different self-administration histories.
    Young AM; Woods JH
    J Pharmacol Exp Ther; 1981 Sep; 218(3):720-7. PubMed ID: 7264955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists.
    Grant KA; Colombo G; Grant J; Rogawski MA
    Neuropharmacology; 1996; 35(12):1709-19. PubMed ID: 9076750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the reinforcing and discriminative stimulus effects of the N-methyl-D-aspartate competitive antagonist NPC 17742 in rhesus monkeys.
    Nicholson KL; Jones HE; Balster RL
    Behav Pharmacol; 1997 Oct; 8(5):396-407. PubMed ID: 9832979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (+)-N-Allylnormetazocine (NANM)-like discriminative stimulus effects of N-methyl-D-aspartate (NMDA) antagonists.
    Willetts J; Rice A; Balster RL
    Behav Pharmacol; 1990; 1(5):453-458. PubMed ID: 11175430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM; Steele TD; Sharpe LG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801.
    Koek W; Colpaert FC; Woods JH; Kamenka JM
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1019-27. PubMed ID: 2674416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.